ChordNews
← All news

Insulet outlines 21%-22% 2026 constant-currency revenue growth and authorizes $1B share repurchase increase

By ChordNews · First written

Comments 0

Summary

Insulet outlined 2026 constant-currency revenue growth of 21% to 22% while authorizing an increase of $1 billion to its share repurchase program, according to a Seeking Alpha breaking-news item published November 4, 2026. The summary relies only on the headline, as the article text was not available.

This continues an earlier story: Myr Group expects 15% to 18% revenue growth in 2027 and authorizes a $100M share repurchase

Later: Krispy Kreme outlines $1.35B-$1.4B 2026 net revenue, targets 2%-4% systemwide sales growth · Biodesix expects $101M-$103M in 2026 revenue and plans to exit 2026 with about 115 sales reps · Treace outlines $206M-$210M 2026 revenue range while targeting $700M TAM expansion

Timeline

  1. Seeking Alpha

    Source ↗

    Seeking Alpha reports that Insulet outlined 21%-22% constant-currency revenue growth for 2026 while authorizing a $1B increase to its share repurchase program.

Comments

No comments yet.

    to like and comment.